p.15 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay

ACC-AHA 2018 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay 連続表示で読む PDF を別タブで

画像は 15 ページを描画したものです

p.15 抽出テキスト

August 20, 2019 Circulation. 2019;140:e382–e482. DOI: 10.1161/CIR.0000000000000628 e396

CLINICAL STATEMENTS AND GUIDELINES Kusumoto et al 2018 Bradycardia Clinical Practice Guidelines

Congenital heart disease surgery Septal myomectomy for hypertrophic obstructive cardiomyopathy Valve surgery (including percutaneous valve replacement) Extrinsic Autonomic perturbation Carotid sinus hypersensitivity Neurally-mediated syncope/presyncope Physical conditioning Situational syncope Cough Defecation Glottic stimulation Medical procedures Micturition Vomiting Sleep (with or without sleep apnea) Metabolic Acidosis Hyperkalemia Hypokalemia Hypothermia Hypothyroidism Hypoxia Adapted with permission from Mangrum and DiMarcoS3.1-1 and Vogler et al.S3.1-2

Table 5.  Continued Table 5.  Conditions Associated With Bradycardia and Conduction Disorders

Intrinsic Cardiomyopathy (ischemic or nonischemic) Congenital heart disease Degenerative fibrosis Infection/inflammation Chagas disease Diphtheria Infectious endocarditis Lyme disease Myocarditis Sarcoidosis Toxoplasmosis Infiltrative disorders Amyloidosis Hemochromatosis Lymphoma Ischemia/infarction Rheumatological conditions Rheumatoid arthritis Scleroderma Systemic lupus erythematosus Surgical or procedural trauma Cardiac procedures such as ablation or cardiac catheterization

(Continued )

Table 4.  Medications That Can Induce/Exacerbate Bradycardia or Conduction Disorders

Antihypertensive Antiarrhythmic Psychoactive Other Beta adrenergic receptor blockers (including beta adrenergic blocking eye drops used for glaucoma) Adenosine Donepezil Anesthetic drugs (propofol) Clonidine Amiodarone Lithium Cannabis Methyldopa Dronedarone Opioid analgesics Digoxin Non-dihydropyridine calcium channel blockers Flecainide Phenothiazine antiemetics and antipsychotics Ivabradine Reserpine Procainamide Phenytoin Muscle relaxants (eg, succinylcholine) Propafenone Selective serotonin reuptake inhibitors

Quinidine Tricyclic antidepressants Sotalol

Downloaded from http://ahajournals.org by on October 7, 2026